Solid-phase based synthesis of ureidopyrimidinone-peptide conjugates for supramolecular biomaterials

I. Feijter, de, O.J.G.M. Goor, S.I.S. Hendrikse, M. Comellas Aragones, S.H.M. Sontjens, S. Zaccaria, P.P.K.H. Fransen, J.W. Peeters, L.G. Milroy, P.Y.W. Dankers

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)
42 Downloads (Pure)


Supramolecular polymers have shown to be powerful scaffolds for tissue engineering applications. Supramolecular biomaterials functionalized with ureidopyrimidinone (UPy) moieties, which dimerize via quadruple hydrogen-bond formation, are eminently suitable for this purpose. The conjugation of the UPy moiety to biologically active peptides ensures adequate integration into the supramolecular UPy polymer matrix. The structural complexity of UPy–peptide conjugates makes their synthesis challenging and until recently low yielding, thus restricted the access to structurally diverse derivatives. Here we report optimization studies of a convergent solid-phase based synthesis of UPy-modified peptides. The peptide moiety is synthesized using standard Fmoc solid-phase synthesis and the UPy fragment is introduced on the solid-phase simplifying the synthesis and purification of the final UPy–peptide conjugate. The convergent nature of the synthesis reduces the number of synthetic steps in the longest linear sequence compared to other synthetic approaches. We demonstrate the utility of the optimized route by synthesizing a diverse range of biologically active UPy–peptide bioconjugates in multimilligram scale for diverse biomaterial applications.
Original languageEnglish
Pages (from-to)2707-2713
Issue number19
Publication statusPublished - 2015


Dive into the research topics of 'Solid-phase based synthesis of ureidopyrimidinone-peptide conjugates for supramolecular biomaterials'. Together they form a unique fingerprint.

Cite this